CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-15 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $25,000.00 | $0 | |
| 2022-11-08 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $100,000.00 | $0 | |
| 2022-11-01 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $35,000.00 | $0 | |
| 2022-10-27 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $7,500.00 | $0 | |
| 2022-10-14 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $50,000.00 | $0 | |
| 2022-09-30 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $110,000.00 | $0 | |
| 2022-09-23 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $75,000.00 | $0 | |
| 2022-09-16 | Rodrigues Dominic Director | Purchase · Series D Convertible Preferred Stock | +11,416,262 | $0.29 | $3.3M | 11,416,262 |
| 2022-09-01 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2022-07-27 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $75,000.00 | $0 | |
| 2022-07-15 | Pershing Edward Director | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $150,000.00 | $0 | |
| 2021-08-16 | Raines Heather CFO | Grant or award · 8% Unsecured Convertible Promissory Note due 2022 | +0 | $200,000.00 | $0 | |
| 2021-06-20 | Raines Heather CFO | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | Raines Heather CFO | Option exercise · Series D-1 Convertible Preferred Stock | +20,289 | 20,289 | ||
| 2021-06-20 | Bailey Webster Director | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | Bailey Webster Director | Option exercise · Series D-1 Convertible Preferred Stock | +41,323 | 41,323 | ||
| 2021-06-20 | Pershing Edward Director | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | Pershing Edward Director | Option exercise · Series D-1 Convertible Preferred Stock | +478,926 | 478,926 | ||
| 2021-06-20 | WACHTER ERIC PHD CTO | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | WACHTER ERIC PHD CTO | Option exercise · Series D-1 Convertible Preferred Stock | +1,393,276 | 1,393,276 |
Page 12 of 17 · 329 trades